Quebec

Quebec’s life sciences ecosystem is a premier global hub, renowned for its seamless integration of biopharmaceutical innovation, medical device manufacturing and advanced healthcare technology.

As a top-tier destination for foreign direct investment, the province, and specifically the Montreal life sciences cluster, hosts the Canadian headquarters of industry giants like Pfizer, Moderna and Merck.

Quebec is best known for its world-leading expertise in precision medicine, oncology and genomics, supported by a robust network of over 700 companies and 55,000 highly skilled workers.

The region's academic research excellence is anchored by prestigious institutions such as McGill University and the Université de Montréal, alongside specialized centers like Mila (the Quebec AI Institute), which fuels breakthroughs in artificial intelligence (AI) for drug discovery.

Quebec’s competitive edge is further sharpened by one of the most attractive R&D tax credit programs in North America, fostering a fertile environment for biotech startups and contract research organizations (CROs).

From the development of next-generation vaccines to innovations in digital health and cardiovascular research, Quebec offers a complete value chain from fundamental discovery to global commercialization.

Strategic collaboration between the public healthcare system and private enterprise ensures that Quebec remains a pivotal gateway for clinical trials and medtech advancement on the international stage.